Home›Companies›Healthcare›Novaestiq

Novaestiq Corp.

Updated Oct 27, 2026·Latest SEC filing Apr 17, 2024·Suggest an edit

About Novaestiq

Novaestiq is a private company based in Southlake, Texas, incorporated in 2021 in Delaware. It has reported $7,378,968 raised in two offerings on Form D since August 2021. Its chief executive is Miles Harrison.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 23, 2021Oct 5, 2021$28,020fully sold1$28,020Equity, Options, Securities on exerciseRule 506(b)Form D ↗
Jul 30, 2021Aug 17, 2021amended Apr 17, 2024$7,350,948of $10.0M target56$131KDebt, Options, Securities on exerciseRule 506(b)Form D/A ↗3 earlier filings
Total, two offerings$7,378,968

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Novaestiq's Form D filed Oct 5, 2021.

Miles Harrison
Miles Harrison
Chief Executive Officer, Director
Also a president and CEO, director at Conexeu.
HA
Humberto Antunes
Executive officer and director
ER
Ethan Rigel
Executive officer

Sources

  1. SECNovaestiq Corp. Form D/A, filed Dec 20, 2023
  2. SECNovaestiq Corp. Form D/A, filed Sep 22, 2021
  3. SECNovaestiq Corp. Form D, filed Aug 17, 2021
  4. SECNovaestiq Corp. filing history